ROTAFLU

This brand name is authorized in Nigeria.

Active ingredients

The drug ROTAFLU contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 7AJO3BO7QN - LORATADINE
 

Loratadine is a tricyclic antihistamine with selective, peripheral H1-receptor activity. Loratadine has no clinically significant sedative or anticholinergic properties in the majority of the population and when used at the recommended dosage.

 
Read more about Loratadine
2
UNII 6V9V2RYJ8N - PSEUDOEPHEDRINE HYDROCHLORIDE
 

Pseudoephedrine is a sympathomimetic agent with direct and indirect effects on adrenergic receptors. It has alpha and beta adrenergic activity and some stimulant effect on the central nervous system. The sympathomimetic effect of pseudoephedrine produces vasoconstriction which in turn relieves nasal congestion.

 
Read more about Pseudoephedrine

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-100697 Tablet ROTAFLU TABLET TAB 5mg; 120mg 1 X 10 76 NF-PP-82072 ROTAFLU TABLET LORATADINE 5mg & PSESUDOEPHEDRINE HCL 120mg TABLET EACH SRT TABLET CONTAINS: (12 hours) LORATADINE USP 5mg, PSEUDOEPHEDRINE HCL 120mg, Excipients Q.S. Drugs Imported Products 1 X 10 TAB Over The Counter (OTC) 4/3/2019 ROTAMEDICS PHARMACY LIMITED, RESERVATION ROAD G.R.A ILORIN ILORIN KWARA 7055888798 rotamedics@gmail.com M/S RELAX BIOTECH.PVT.LTD, 862/1 G.I.D.C., MAKARPURA BARODA-390010 INDIA, India 31/01/2024

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-100697

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.